MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells

Oncology Reports

Volumn 34, Issue 4, 2015, Pages 1845-1852

  Yu, Lei ^a   Yang, Yanming ^a   Hou, Jiguang ^a   Zhai, Chengwei ^a   Song, Yunhao ^a   Zhang, Zhiliang ^a   Qiu, Ling ^a   Jia, Xiaojing ^a  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

AKT; Apoptosis; Epithelialmesenchymal transition; Metastasis; MiRNA 144; MiRNAs; PTEN

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 9; MICRORNA; MICRORNA 144; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; CADHERIN; MIRN144 MICRORNA, HUMAN; PTEN PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CANCER RADIOTHERAPY; CASPASE ASSAY; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WST-1 ASSAY; BIOSYNTHESIS; BREAST NEOPLASMS; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; RADIATION TOLERANCE; TUMOR CELL LINE; TUMOR INVASION;

APOPTOSIS; BREAST NEOPLASMS; CADHERINS; CASPASE 3; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; PTEN PHOSPHOHYDROLASE; RADIATION TOLERANCE;

EID: 84939176708     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4173     Document Type: Article

References (37)

1. Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64: 9-29, 2014.
2. Donepudi MS, Kondapalli K, Amos SJ and Venkanteshan P: Breast cancer statistics and markers. J Cancer Res Ther 10: 506-511, 2014.
3. Abels JC, Gorham AT, Pack GT and Rhoads CP: Metabolic studies in patients with cancer of the gastro-intestinal tract. I. Plasma vitamin A levels in patients with malignant neoplastic disease, particularly of the gastro-intestinal tract. J Clin Invest 20: 749-764, 1941.
4. Peitzsch C, Kurth I, Kunz-Schughart L, Baumann M and Dubrovska A: Discovery of the cancer stem cell related determinants of radioresistance. Radiother Oncol 108: 378-387, 2013.
5. Rich JN: Cancer stem cells in radiation resistance. Cancer Res 67: 8980-8984, 2007.
6. Pajonk F, Vlashi E and McBride WH: Radiation resistance of cancer stem cells: The 4 R's of radiobiology revisited. Stem Cells 28: 639-648, 2010.
7. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al: Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458: 780-783, 2009.
8. Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y, Zhang J, Yuan J, Wang M, Chen D, Sun Y, et al: ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat Cell Biol 16: 864-875, 2014.
9. Manikandan J, Aarthi JJ, Kumar SD and Pushparaj PN: OncomiRs: The potential role of non-coding microRNAs in understanding cancer. Bioinformation 2: 330-334, 2008.
10. Esquela-Kerscher A and Slack FJ: OncomiRs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
11. Lee YS and Dutta A: MicroRNAs in cancer. Annu Rev Pathol 4: 199-227, 2009.
12. Nana-Sinkam SP and Croce CM: MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: Towards clinical use. Genome Biol 15: 445, 2014.
13. Zhou W, Shi G, Zhang Q, Wu Q, Li B and Zhang Z: MicroRNA-20b promotes cell growth of breast cancer cells partly via targeting phosphatase and tensin homologue (PTEN). Cell Biosci 4: 62, 2014.
14. Li L, Xiao B, Tong H, Xie F, Zhang Z and Xiao GG: Regulation of breast cancer tumorigenesis and metastasis by miRNAs. Expert Rev Proteomics 9: 615-625, 2012.
15. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007.
16. Huang X, Taeb S, Jahangiri S, Emmenegger U, Tran E, Bruce J, Mesci A, Korpela E, Vesprini D, Wong CS, et al: miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1. Cancer Res 73: 6972-6986, 2013.
17. Kato M, Paranjape T, Müller RU, Nallur S, Gillespie E, Keane K, Esquela-Kerscher A, Weidhaas JB and Slack FJ: The MIR-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene 28: 2419-2424, 2009.
18. Keller A, Leidinger P, Vogel B, Backes C, ElSharawy A, Galata V, Mueller SC, Marquart S, Schrauder MG, Strick R, et al: miRNAs can be generally associated with human pathologies as exemplified for MIR-144. BMC Med 12: 224, 2014.
19. Zhang J, Qin X, Sun Q, Guo H, Wu X, Xie F, Xu Q, Yan M, Liu J, Han Z, et al: Transcriptional control of PAX4-regulated MIR-144/451 modulates metastasis by suppressing ADAMs expression. Oncogene 34: 3283-3295, 2015.
20. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64: 252-271, 2014.
21. Nakshatri H: Radiation resistance in breast cancer: Are CD44+/CD24-/proteosome low/PKH26+ cells to blame? Breast Cancer Res 12: 105, 2010.
22. Tessner TG, Muhale F, Riehl TE, Anant S and Stenson WF: Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation. J Clin Invest 114: 1676-1685, 2004.
23. Cellini F, Morganti AG, Genovesi D, Silvestris N and Valentini V: Role of microRNA in response to ionizing radiations: Evidences and potential impact on clinical practice for radiotherapy. Molecules 19: 5379-5401, 2014.
24. Iwaya T, Yokobori T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, et al: Downregulation of MIR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis 33: 2391-2397, 2012.
25. Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang Z, Qiu F and Lin J: MIR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J 280: 4531-4538, 2013.
26. Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, Sheldon H, Taylor M, Harris AL and Ragoussis J: microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res 71: 5635-5645, 2011.
27. McAllister SD, Murase R, Christian RT, Lau D, Zielinski AJ, Allison J, Almanza C, Pakdel A, Lee J, Limbad C, et al: Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res Treat 129: 37-47, 2011.
28. Webb CP and Vande Woude GF: Genes that regulate metastasis and angiogenesis. J Neurooncol 50: 71-87, 2000.
29. Kalluri R and Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784, 2003.
30. Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelialmesenchymal transition: New insights in signaling, development, and disease. J Cell Biol 172: 973-981, 2006.
31. Liang WT, Cheng ZY, Jia ZQ and Wang BY: PTEN: A new target in inhibiting of tumor invasion and metastasis. Sheng Li Ke Xue Jin Zhan 42: 201-205, 2011 (In Chinese).
32. Carracedo A and Pandolfi PP: The PTEN-PI3K pathway: Of feedbacks and cross-talks. Oncogene 27: 5527-5541, 2008.
33. Hühns M, Salem T, Schneider B, Krohn M, Linnebacher M and Prall F: PTEN mutation, loss of heterozygosity, promoter methylation and expression in colorectal carcinoma: Two hits on the gene? Oncol Rep 31: 2236-2244, 2014.
34. Kechagioglou P, Papi RM, Provatopoulou X, Kalogera E, Papadimitriou E, Grigoropoulos P, Nonni A, Zografos G, Kyriakidis DA and Gounaris A: Tumor suppressor PTEN in breast cancer: Heterozygosity, mutations and protein expression. Anticancer Res 34: 1387-1400, 2014.
35. Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, Huang J, Gleave M and Wu H: Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res 72: 1878-1889, 2012.
36. Wang ZX, Lu BB, Wang H, Cheng ZX and Yin YM: MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. Arch Med Res 42: 281-290, 2011.
37. Ma F, Zhang J, Zhong L, Wang L, Liu Y, Wang Y, Peng L and Guo B: Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/catenin signaling. Gene 535: 191-197, 2014.